# Argus 2.0 Adoption Study

Study · id `cardio:ct-nct07425236` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07425236](<https://clinicaltrials.gov/study/NCT07425236>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07425236

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT07425236. Non-randomized; no masking; primary purpose device feasibility. Start 2026-04-19 (anticipated); primary completion 2026-08-19 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose device feasibility
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT07425236, source copy `cardio:ctgov-nct07425236-2026-02-20`, retrieved 2026-10-26)
- Planned start: 2026-04-19 (anticipated) (ClinicalTrials.gov record NCT07425236, source copy `cardio:ctgov-nct07425236-2026-02-20`, retrieved 2026-10-26)
- Primary completion: 2026-08-19 (anticipated) (ClinicalTrials.gov record NCT07425236, source copy `cardio:ctgov-nct07425236-2026-02-20`, retrieved 2026-10-26)
- Completion: 2027-08-19 (anticipated) (ClinicalTrials.gov record NCT07425236, source copy `cardio:ctgov-nct07425236-2026-02-20`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07425236, source copy `cardio:ctgov-nct07425236-2026-02-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07425236-2026-02-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Argus 2.0 Adoption Study
- Condition: Diabetes
- Condition: Diabetes Mellitus, Type 1 Diabetes
- Condition: Diabetes Mellitus, Type 2
- Condition: Prediabetes
- Intervention (Device): KOS Argus Continuous Glucose Monitoring System
- Lead sponsor: KOS Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Prediabetes (`cardio:prediabetes`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: 19f1f0fb47b43b1ba568913d8b6de1caf3e959443748d24e30914cdeb66f4e90
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
